Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-30 Sale | 2022-07-05 4:30 pm | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 29,767 | $18.8 | $559,577 | 102,529 (Direct) | View |
| 2022-04-04 Sale | 2022-04-05 5:34 pm | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 10,000 | $30.04 | $300,395 | 207,795 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 5:00 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 19,800 | $29 | $574,200 | 77,511 (Direct) | View |
| 2021-09-22 Sale | 2021-09-24 5:00 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 6,600 | $29 | $191,400 | 107,311 (Direct) | View |
| 2021-07-15 Sale | 2021-07-16 5:00 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 3,300 | $31.54 | $104,088 | 4,700 (Direct) | View |
| 2021-06-01 Sale | 2021-06-02 5:00 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 3,000 | $33.34 | $100,020 | 6,950 (Direct) | View |
| 2021-05-03 Sale | 2021-05-05 5:00 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 3,000 | $38.22 | $114,647 | 9,950 (Direct) | View |
| 2021-04-01 Sale | 2021-04-05 4:08 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 3,000 | $35.43 | $106,281 | 12,950 (Direct) | View |
| 2021-03-09 Sale | 2021-03-11 5:51 pm | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 10,000 | $35.48 | $354,845 | 187,985 (Direct) | View |
| 2021-03-09 Sale | 2021-03-11 5:50 pm | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $35.71 | $178,551 | 217,795 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 6:18 pm | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 10,000 | $35.45 | $354,507 | 72,578 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:08 pm | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 3,000 | $33.87 | $101,618 | 15,950 (Direct) | View |
| 2021-02-24 Sale | 2021-02-26 4:50 pm | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 10,000 | $34.24 | $342,392 | 197,985 (Direct) | View |
| 2021-02-24 Sale | 2021-02-26 4:49 pm | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $34.19 | $170,933 | 222,795 (Direct) | View |
| 2021-02-24 Sale | 2021-02-26 4:48 pm | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 3,000 | $34.18 | $102,529 | 82,478 (Direct) | View |
| 2021-02-11 Sale | 2021-02-16 5:10 pm | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 1,446 | $35.43 | $51,238 | 207,985 (Direct) | View |
| 2021-02-11 Sale | 2021-02-16 5:08 pm | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 1,428 | $35.39 | $50,542 | 85,478 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 7:25 pm | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 11,206 | $35.17 | $394,085 | 209,431 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 7:25 pm | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 3,569 | $35.18 | $125,565 | 222,795 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 7:25 pm | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 11,372 | $35.17 | $399,910 | 86,906 (Direct) | View |
| 2021-02-02 Sale | 2021-02-04 5:40 pm | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 3,278 | $35.07 | $114,970 | 234,018 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-30 Exercise | 2022-07-05 4:30 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 29,767 | $16 | 102,529 (Direct) | View |
| 2022-06-30 Exercise | 2022-07-05 4:30 pm | 2012-07-10 2022-07-10 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 29,767 | $0 | 102,529 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:45 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 951,821 | $0 | 1,443,994 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:43 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 182,470 | $0 | 300,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:42 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 495,211 | $0 | 722,729 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:41 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | GLASSPOOL JOHN Director | 91,235 | $0 | 150,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:41 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | SCHMIDT ERIC THOMAS Director | 91,235 | $0 | 150,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:39 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | Ence Chuck CA and Compliance Officer | 495,404 | $0 | 722,236 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:38 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 91,235 | $0 | 150,000 (Direct) | View |
| 2022-04-04 Exercise | 2022-04-05 5:34 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 10,000 | $3.24 | 207,795 (Direct) | View |
| 2022-04-04 Exercise | 2022-04-05 5:34 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 10,000 | $0 | 207,795 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 5:00 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 19,800 | $3.24 | 77,511 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 5:00 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 19,800 | $0 | 77,511 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 5:01 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 20,000 | $3.24 | 217,795 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 5:01 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 20,000 | $0 | 217,795 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:31 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 492,173 | $0 | 492,173 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:31 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | GLASSPOOL JOHN Director | 58,765 | $0 | 58,765 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:31 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | SCHMIDT ERIC THOMAS Director | 58,765 | $0 | 58,765 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:30 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 227,518 | $0 | 227,518 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:30 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 117,530 | $0 | 117,530 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:30 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | Ence Chuck CAO and Compliance Officer | 226,832 | $0 | 226,832 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:30 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 58,765 | $0 | 58,765 (Direct) | View |
| 2021-09-22 Exercise | 2021-09-24 5:00 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 10,000 | $4.6 | 107,311 (Direct) | View |
| 2021-09-22 Exercise | 2021-09-24 5:00 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 1,900 | $0 | 107,311 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 5:00 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 10,000 | $4.6 | 117,200 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-19 5:00 pm | 2018-12-20 2028-12-20 | RELMADA THERAPEUTICS Inc | RLMD | CASAMENTO CHARLES J Director | 10,000 | $0 | 117,200 (Direct) | View |
| 2021-03-09 Exercise | 2021-03-11 5:51 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 10,000 | $3.24 | 187,985 (Direct) | View |
| 2021-03-09 Exercise | 2021-03-11 5:51 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 10,000 | $0 | 187,985 (Direct) | View |
| 2021-03-09 Exercise | 2021-03-11 5:50 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $3.24 | 217,795 (Direct) | View |
| 2021-03-09 Exercise | 2021-03-11 5:50 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $0 | 217,795 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-10 6:18 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 10,000 | $3.24 | 72,578 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-10 6:18 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 10,000 | $0 | 72,578 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 4:50 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 10,000 | $3.24 | 197,985 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 4:50 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 10,000 | $0 | 197,985 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 4:49 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $3.24 | 222,795 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 4:49 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $0 | 222,795 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 4:48 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 3,000 | $3.24 | 82,478 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 4:48 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 3,000 | $0 | 82,478 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-17 6:37 pm | 2017-10-04 2024-10-04 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 5,000 | $6 | 187,295 (Direct) | View |
| 2021-02-11 Exercise | 2021-02-16 5:10 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 1,446 | $3.24 | 207,985 (Direct) | View |
| 2021-02-11 Exercise | 2021-02-16 5:10 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 1,446 | $0 | 207,985 (Direct) | View |
| 2021-02-11 Exercise | 2021-02-16 5:08 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 1,428 | $3.24 | 85,478 (Direct) | View |
| 2021-02-11 Exercise | 2021-02-16 5:08 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 1,428 | $0 | 85,478 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:25 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 11,206 | $3.24 | 209,431 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:25 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 11,206 | $0 | 209,431 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:25 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 3,569 | $3.24 | 222,795 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:25 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Kelly Paul Edward Director | 3,569 | $0 | 222,795 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:25 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 11,372 | $3.24 | 86,906 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 7:25 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | Shenouda Maged CFO | 11,372 | $0 | 86,906 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-04 5:42 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 13,281 | $3.24 | 220,637 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-04 5:42 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 13,281 | $0 | 220,637 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-04 5:40 pm | N/A N/A | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 3,278 | $3.24 | 234,018 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-04 5:40 pm | 2017-10-20 2027-10-20 | RELMADA THERAPEUTICS Inc | RLMD | TRAVERSA SERGIO CEO | 3,278 | $0 | 234,018 (Direct) | View |